Literature DB >> 20544919

Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia.

Erik H Niks1, Jan B M Kuks, John H J Wokke, Henk Veldman, Egbert Bakker, Jan J G M Verschuuren, Jaap J Plomp.   

Abstract

Autoantibodies to muscle-specific kinase (MuSK) can cause myasthenia gravis (MG). The pathophysiological mechanism remains unknown. We report in vitro electrophysiological and histological studies of the neuromuscular junction in a MuSK MG patient. Low levels of presynaptic acetylcholine release and small miniature endplate potentials were found. This combination of pre- and postsynaptic abnormalities was supported by histology, revealing partially denervated postsynaptic areas, and some degeneration of postsynaptic folds. Results suggest that anti-MuSK antibodies reduce the stability of muscle-nerve contact.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544919     DOI: 10.1002/mus.21642

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  19 in total

Review 1.  Practical Anatomy of the Neuromuscular Junction in Health and Disease.

Authors:  Hiroshi Nishimune; Kazuhiro Shigemoto
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

2.  Anti-MuSK autoantibodies block binding of collagen Q to MuSK.

Authors:  Y Kawakami; M Ito; M Hirayama; K Sahashi; B Ohkawara; A Masuda; H Nishida; N Mabuchi; A G Engel; K Ohno
Journal:  Neurology       Date:  2011-10-19       Impact factor: 9.910

3.  Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction.

Authors:  Nazanin Ghazanfari; Marco Morsch; Stephen W Reddel; Simon X Liang; William D Phillips
Journal:  J Physiol       Date:  2014-05-23       Impact factor: 5.182

4.  Morphological aspects of neuromuscular junctions and gene expression of nicotinic acetylcholine receptors (nAChRs) in skeletal muscle of rats with heart failure.

Authors:  Paula Aiello Tomé de Souza; Selma Maria Michelin Matheus; Eduardo Paulino Castan; Dijon Henrique Salomé Campos; Antônio Carlos Cicogna; Robson Francisco Carvalho; Maeli Dal-Pai-Silva
Journal:  J Mol Histol       Date:  2011-09-18       Impact factor: 2.611

5.  Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes.

Authors:  David P Richman; Kayoko Nishi; Stuart W Morell; Jolene Mi Chang; Michael J Ferns; Robert L Wollmann; Ricardo A Maselli; Joachim Schnier; Mark A Agius
Journal:  Arch Neurol       Date:  2011-12-12

6.  Animal models of antimuscle-specific kinase myasthenia.

Authors:  David P Richman; Kayoko Nishi; Michael J Ferns; Joachim Schnier; Peter Pytel; Ricardo A Maselli; Mark A Agius
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

Review 7.  The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.

Authors:  Inga Koneczny; Judith Cossins; Angela Vincent
Journal:  J Anat       Date:  2013-03-04       Impact factor: 2.610

8.  The role of great auricular-facial nerve neurorrhaphy in facial nerve damage.

Authors:  Yan Sun; Limei Liu; Yuechen Han; Lei Xu; Daogong Zhang; Haibo Wang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

9.  Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies.

Authors:  Giovanna Cenacchi; Valentina Papa; Papa Valentina; Marina Fanin; Fanin Marina; Elena Pegoraro; Pegoraro Elena; Corrado Angelini; Angelini Corrado
Journal:  J Neurol       Date:  2010-11-19       Impact factor: 4.849

10.  Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling.

Authors:  Kenji Otsuka; Mikako Ito; Bisei Ohkawara; Akio Masuda; Yu Kawakami; Ko Sahashi; Hiroshi Nishida; Naoki Mabuchi; Akemi Takano; Andrew G Engel; Kinji Ohno
Journal:  Sci Rep       Date:  2015-09-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.